Nirupama Putcha (Johns Hopkins University, Baltimore, MD, USA) and Elizabeth Oelsner (Columbia University Medical Center, New York, NY, USA) speak from the 2019 ATS conference in Dallas, TX, USA about their study into patients with asthma–chronic obstructive pulmonary disease (COPD) overlap (ACO) and its prognostic impact compared with asthma and COPD; the implications of their results for addressing unmet needs in ACO, and the further work needs to be performed in order to improve our understanding of the prognostic impact of ACO.
Questions
1. Please outline what is currently known about the characteristics of patients with asthma–chronic obstructive pulmonary disease (COPD) overlap (ACO) and its prognostic impact compared with asthma and COPD. (0:04)
2. Were there any specific features of your study design that allowed you to better understand the prognostic impact of ACO compared with previous studies? (2:31)
3. What did the results of your study demonstrate in terms of the prognostic impact of ACO compared with asthma or COPD? (3:17)
4. Please describe the implications of your results for addressing unmet needs in ACO? (5:05)
5. What further work needs to be performed in order to improve our understanding of the prognostic impact of ACO? (5:32)
Speaker disclosure: Nirupama Putcha and Elizabeth Oelsner have nothing to disclose in relation to this video interview.
touchRESPIRATORY.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.
Filmed at ATS 2019, Dallas, TX, USA, May 2019.
